Sales rise 47.95% to Rs 123.52 crore
Net profit of Tatva Chintan Pharma Chem reported to Rs 9.92 crore in the quarter ended September 2025 as against net loss of Rs 0.66 crore during the previous quarter ended September 2024. Sales rose 47.95% to Rs 123.52 crore in the quarter ended September 2025 as against Rs 83.49 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales123.5283.49 48 OPM %17.986.68 -PBDT22.725.79 292 PBT13.66-1.02 LP NP9.92-0.66 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
